Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3028118 | PMC |
| http://dx.doi.org/10.1136/bcr.06.2008.0316 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
A systematic review on treatment-related mucocutaneous reactions in COVID-19 patients.
Dermatol Ther
January 2021
Department of Dermatology, Rasoul Akram Hospital, Iran University of Medical Sciences (IUMS), Tehran, Iran.
Most of drugs could have certain mucocutaneous reactions and COVID-19 drugs are not an exception that we focused. We systematically reviewed databases until August 15, 2020 and among initial 851 articles, 30 articles entered this study (20 case reports, 4 cohorts, and 6 controlled clinical trials). The types of reactions included AGEP, morbiliform drug eruptions, vasculitis, DRESS syndrome, urticarial vasculitis, and so on.
View Article and Find Full Text PDFHydroxychloroqine induced dilated cardiomyopathy and lupus mastitis.
BMJ Case Rep
November 2011
Hera General Hospital, Medicine, 4a/201, Hera General, Hospital, Makkah, 21955, Saudi Arabia.
[Gastrointestinal side effects in the therapy of rheumatologic diseases].
Z Gastroenterol
November 2002
Medizinische Poliklinik, Klinikum der Universität München - Innenstadt, Ludwig-Maximilians-Universität München, Germany.
Antirheumatic drugs may lead to a number of relevant gastrointestinal complications. Symptomatical treatments with glucocorticoids and non steroidal antirheumatic drugs (NSAD) are known to induce gastric or duodenal ulcers, above all under combination therapies. Side effects of DMARD's (methotrexate, leflunomide, hydroxy/chloroquine, sulfasalazine) include unspecifical gastrointestinal symptoms like nausea, vomiting and diarrhea as well as induction of ulcerative mucosal lesions (methotrexate) and occurrence of a hepatopathy.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!